(Q46709661)

24 December 2017

title

Pleural effusions in patients with chronic myeloid leukaemia treated with dasatinib may have an immune-mediated pathogenesis (English)

1 reference

24 December 2017

1 reference

dasatinib monohydrate

1 reference

1 reference

Hugues de Lavallade

1

1 reference

24 December 2017

Sinthiya Punnialingam

2

1 reference

24 December 2017

Dragana Milojkovic

3

1 reference

24 December 2017

Marco Bua

4

1 reference

24 December 2017

Jamshid S Khorashad

5

1 reference

24 December 2017

Ian H Gabriel

6

1 reference

24 December 2017

Aristeidis Chaidos

7

1 reference

24 December 2017

Eduardo Olavarria

8

1 reference

24 December 2017

John M Goldman

9

1 reference

24 December 2017

Jane F Apperley

10

1 reference

24 December 2017

David Marin

11

1 reference

24 December 2017

language of work or name

English

0 references

publication date

7 March 2008

1 reference

24 December 2017

British Journal of Haematology

published in

1 reference

24 December 2017

volume

141

1 reference

24 December 2017

issue

5

1 reference

24 December 2017

page(s)

745-747

1 reference

24 December 2017

Hypersensitivity pneumonitis related to imatinib mesylate

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07108.X

Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07108.X

Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07108.X

Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07108.X

Pleural Effusion in Patients With Chronic Myelogenous Leukemia Treated With Dasatinib After Imatinib Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07108.X

Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07108.X

Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07108.X

10.1111/J.1365-2141.2008.07108.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

18331365

1 reference

24 December 2017